Back
Adverum Biotechnologies, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
ADVM
Adverum Biotechnologies, Inc.
Last Price:
$4.38
Seasonality Move:
-11.49%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAdverum Biotechnologies, Inc. Stock Forecast
-
Is Adverum Biotechnologies, Inc. Stock Undervalued?The current Adverum Biotechnologies, Inc. [ADVM] share price is $4.36. The Score for ADVM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Adverum Biotechnologies, Inc. Stock Go Up Next Year?
Data Unavailable
Adverum Biotechnologies, Inc. Stock Rating
Data Unavailable
Adverum Biotechnologies, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adverum.com
52-Week Data
52-Week High:
5.75
52-Week Low:
1.78
Prediction Charts
Market Cap:
96.3M
Price in USD:
4.36
Volume:
0
Beta:
1.41
Technical Analysis
SMA50:
4.37
SMA100:
3.77
SMA200:
3.48
52-Wk Change:
-23.78%
Stock Predictions
-
Is Adverum Biotechnologies, Inc. stock public?Yes, Adverum Biotechnologies, Inc. is a publicly traded company.
-
What is the Adverum Biotechnologies, Inc. stock quote today?The Adverum Biotechnologies, Inc. stock price is 4.36 USD today.
-
How to buy Adverum Biotechnologies, Inc. stock online?You can buy Adverum Biotechnologies, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 4.15 | 4.12 | 4.21 | 4.08 |
| Nov-25 | 4.12 | 4.09 | 4.16 | 3.99 |
| Nov-26 | 4.09 | 4.16 | 4.17 | 4.09 |
| Nov-28 | 4.17 | 4.12 | 4.18 | 4.12 |
| Dec-1 | 4.11 | 4.20 | 4.23 | 4.07 |
| Dec-2 | 4.20 | 4.16 | 4.22 | 4.15 |
| Dec-3 | 4.17 | 4.17 | 4.19 | 4.16 |
| Dec-4 | 4.17 | 4.17 | 4.24 | 4.17 |
| Dec-5 | 4.15 | 4.26 | 4.28 | 4.15 |
| Dec-8 | 4.24 | 4.36 | 4.38 | 4.23 |
| Dec-9 | 4.36 | 4.36 | 4.36 | 4.36 |
| Dec-10 | 4.36 | 4.36 | 4.36 | 4.36 |
| Dec-11 | 4.36 | 4.36 | 4.36 | 4.36 |
| Dec-12 | 4.36 | 4.36 | 4.36 | 4.36 |
Adverum Biotechnologies, Inc. Earnings
Data Unavailable
Adverum Biotechnologies, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.69 per share, and an increase next year of $3.49 per share.
* Adverum Biotechnologies, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.